Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach
Alzheimer's disease (AD) is an enigmatic neurological illness that offers few treatment
options. Recent exploration has highlighted the crucial connection of the Wnt signaling …
options. Recent exploration has highlighted the crucial connection of the Wnt signaling …
Advancements in nose-to-brain drug targeting for Alzheimer's disease: a review of nanocarriers and clinical insights
K Komal, R Ghosh, D Sil, R Sharma, S Kumar… - …, 2025 - Springer
Alzheimer's disease (AD) is a type of neurodegenerative disease that describes cognitive
decline and memory loss resulting in disability in movement, memory, speech etc. Which first …
decline and memory loss resulting in disability in movement, memory, speech etc. Which first …
Current advances in our understanding of circular RNA (circRNA) in Alzheimer's disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy …
Y Zhao, VR Jaber, WJ Lukiw - Frontiers in Drug Discovery, 2022 - frontiersin.org
Circular RNAs (circRNAs) represent a large, naturally occurring family of extremely stable
single-stranded RNAs (ssRNAs) with covalently linked 3′ and 5′ ends. Traditional …
single-stranded RNAs (ssRNAs) with covalently linked 3′ and 5′ ends. Traditional …
Reconsidering red blood cells as the diagnostic potential for neurodegenerative disorders
Abstract Background Red blood cells (RBCs) are usually considered simple cells and
transporters of gases to tissues. Hypothesis However, recent research has suggested that …
transporters of gases to tissues. Hypothesis However, recent research has suggested that …
TDP-43 as a potential retinal biomarker for neurodegenerative diseases
M Glashutter, P Wijesinghe… - Frontiers in Neuroscience, 2025 - frontiersin.org
TDP-43 proteinopathies are a spectrum of neurodegenerative diseases (NDDs)
characterized by the pathological cytoplasmic aggregation of the TDP-43 protein. These …
characterized by the pathological cytoplasmic aggregation of the TDP-43 protein. These …
α-synuclein as an emerging pathophysiological biomarker of Alzheimer's disease
MF Beatino, C De Luca, N Campese… - Expert Review of …, 2022 - Taylor & Francis
Introduction α-syn aggregates represent the pathological hallmark of synucleinopathies as
well as a frequent copathology (almost 1/3 of cases) in AD. Recent research indicates a …
well as a frequent copathology (almost 1/3 of cases) in AD. Recent research indicates a …
SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal Dementia
Background: Accurate diagnosis of Alzheimer's disease (AD) and frontotemporal dementia
(FTD) represents a health issue due to the absence of disease traits. We assessed the …
(FTD) represents a health issue due to the absence of disease traits. We assessed the …
[HTML][HTML] Use of Laughter for the Detection of Parkinson's Disease: Feasibility Study for Clinical Decision Support Systems, Based on Speech Recognition and …
M Terriza, J Navarro, I Retuerta, N Alfageme… - International journal of …, 2022 - mdpi.com
Parkinson's disease (PD) is an incurable neurodegenerative disorder which affects over 10
million people worldwide. Early detection and correct evaluation of the disease is critical for …
million people worldwide. Early detection and correct evaluation of the disease is critical for …
Brain Network Dynamics and Multiscale Modelling of Neurodegenerative Disorders: A Review
It is essential to understand the complex structure of the human brain to develop new
treatment approaches for neurodegenerative disorders (NDDs). This review paper …
treatment approaches for neurodegenerative disorders (NDDs). This review paper …
Exploring cognitive and neuroimaging profiles of dementia subtypes of individuals with dementia in the Democratic Republic of Congo
J Ikanga, SS Patel, M Schwinne… - Frontiers in Aging …, 2025 - search.proquest.com
Objective: The 2024 Alzheimer's Association (AA) research diagnostic criteria for
Alzheimer's Disease (AD) considers fluid biomarkers, including promising blood-based …
Alzheimer's Disease (AD) considers fluid biomarkers, including promising blood-based …